Zenas BioPharma appoints Orlando Oliveira as CCO

US immunology focused biotech Zenas BioPharma says it has appointed Orlando Oliveira as its chief commercial officer (CCO).

With a career spanning nearly 25 years, Mr Oliveira brings a wealth of experience building high-performing global commercial teams, driving revenue growth, and fostering strategic partnerships in the biotechnology and pharmaceutical industry, the company noted.

“As we continue to advance multiple mid- to late-stage clinical development programs, we are thrilled to welcome Orlando to the Zenas leadership team,” said Joe Farmer, Zenas’ president and chief operating officer. “His expertise and track record of building and leading high performing commercial teams will be instrumental in the establishment of the obexelimab franchise and achievement of our goal to bring obexelimab to patients worldwide. We will benefit immensely from Orlando’s broad commercial knowledge and leadership as Zenas evolves to become an integrated development and commercial biopharmaceutical company,” he added.